UK MPs turn up the heat on EU medtech review with proposals to avert 'shopping' for CE marks
This article was originally published in SRA
Executive Summary
The UK’s House of Commons Science & Technology Committee (STC) has weighed into the EU medtech regulation debate with stricter pre- and post-market proposals than those put on the table by the European Commission in its medical device directives revision texts1,2.